A case of myositis with dropped head syndrome and anti-titin antibody positivity induced by pembrolizumab.

Using immune checkpoint inhibitors (ICIs), which target regulatory pathways in T cells to enhance anti-tumour responses, leads to important clinical advances and provides new weapons against cancer...